MCAC in November
This article was originally published in The Gray Sheet
Evidence on benefits, risks and cost of bariatric surgery will be weighed by the Medicare Coverage Advisory Committee in Baltimore Nov. 4. Inamed, which offers the Lap-Band gastric banding system, plans to attend the meeting. CMS recently overturned its non-coverage policy for obesity (1"The Gray Sheet" July 26, 2004, p. 14)...
You may also be interested in...
Inamed plans to work with CMS to obtain Medicare coverage for its Lap-Band gastric banding system following the agency's decision to overhaul its non-coverage policy for obesity treatments
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.